Shannon Payne

Title: Innovations by Inventor Shannon Payne

Introduction

Shannon Payne is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cellular proliferative disorders through his innovative research and patented technologies. With a total of 3 patents, his work has the potential to improve diagnosis and treatment options for patients suffering from these conditions.

Latest Patents

Shannon Payne's latest patents include groundbreaking methods and nucleic acids for analyzing cellular proliferative disorders. One of his inventions provides methods, nucleic acids, and kits for detecting cell proliferative disorders. This patent also includes genomic sequences of RASSF'-2, with methylation patterns that enhance the detection of such disorders, ultimately aiding in better diagnosis and treatment for patients. Another significant patent focuses on the analysis of gene expression associated with the development of prostate cell proliferative disorders. This invention offers methods, nucleic acids, and kits for detecting these disorders, revealing genomic sequences that improve detection and facilitate better patient outcomes.

Career Highlights

Shannon Payne is currently associated with Epigenomics AG, where he continues to advance his research in the field of genomics and cellular biology. His work is instrumental in bridging the gap between scientific research and practical medical applications.

Collaborations

Shannon collaborates with esteemed colleagues, including Catherine E Lofton-Day and Andrew Z Sledziewski, who contribute to his research endeavors and help drive innovation in the field.

Conclusion

Shannon Payne's contributions to the field of cellular proliferative disorders through his patents and research at Epigenomics AG highlight his commitment to improving patient care. His innovative methods and nucleic acids are paving the way for advancements in diagnosis and treatment, making a significant impact in the medical community.